D. Charron

ANALYSIS OF HLA HAPLOTYPES IN FAMILIES WITH TYPE 1 DIABETES MELLITUS IN LA RÉUNION ISLAND

J. Feugeas, R. Krishnamoorthy, C. Montchamp-Moreau, 1996, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Influence of metabolic and genetic factors on tumour necrosis factor-alpha and lymphotoxin-alpha production in insulin-dependent diabetes mellitus.

J. Wautier, A. Marcelli-Barge, J. Feugeas, 1997, Diabetes & Metabolism.

Myasthenia Gravis Is Associated with Two DQα/β Heterodimers

S. Berrih-Aknin, J. Hors, I. Khalil, 1993 .

Alogliptin: a new dipeptidyl peptidase-4 inhibitor for type 2 diabetes mellitus.

Courtney I. Jarvis, D. Charron, A. Cabrera, 2013, The Annals of pharmacotherapy.

NOD2/CARD15 and IL23R genetic variability in 204 Algerian Crohn's disease.

R. Tamouza, R. Djidjik, M. Abbadi, 2014, Clinics and research in hepatology and gastroenterology.